camylofin + paracetamol

Anafortan Plus is a fixed-dose combination medication developed and marketed by AGP Pharma, primarily used for the management of spasmodic pain. It consists of camylofin dihydrochloride and paracetamol (acetaminophen). Camylofin is a dual-action antispasmodic that functions as a muscarinic acetylcholine receptor antagonist and a phosphodiesterase-4 (PDE4) inhibitor, leading to the relaxation of smooth muscles in the gastrointestinal, biliary, and genitourinary tracts. Paracetamol serves as an analgesic and antipyretic by inhibiting prostaglandin synthesis, primarily within the central nervous system. The Plus variant is distinguished by a higher dose of camylofin (50 mg) compared to the standard Anafortan formulation (25 mg), providing enhanced relief for acute conditions such as renal colic, biliary colic, and severe spasmodic dysmenorrhea.

Brand names

Anafortan Plus

Other names

camylofin + acetaminophen